This is why Merck is buying Cidara Therapeutics for $9.2 billion, and why Wall Street is happy
MarketWatch·2025-11-14 16:20

核心观点 - 公司面临Keytruda的专利悬崖挑战 [1] - 公司面临Gardasil市场动荡的挑战 [1]